Trials / Conditions / Moderate to Severe Glabellar Frown Lines
Moderate to Severe Glabellar Frown Lines
3 registered clinical trials studyying Moderate to Severe Glabellar Frown Lines.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Study to Investigate the Safety and Duration of Effect of Different Botulinum Toxin A (NT 201) Dose Groups Fol NCT03806933 | Merz Aesthetics GmbH | Phase 2 |
| Completed | IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines NCT00770211 | Merz Pharmaceuticals GmbH | Phase 3 |
| Completed | IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines No. 2 NCT00770029 | Merz Pharmaceuticals GmbH | Phase 3 |